D-dimer and platelet aggregability are related to thrombotic events in patients with peripheral arterial occlusive disease

被引:38
作者
Komarov, AL
Panchenko, EP
Dobrovolsky, AB
Karpov, YA
Deev, AD
Titaeva, EV
Davletov, KK
Eshkeeva, AR
Markova, LA
机构
[1] Cardiol Res Ctr, Dept Atherothrombosis, Moscow 121552, Russia
[2] Cardiol Res Ctr, Dept Angiol, Moscow 121552, Russia
[3] Natl Res Ctr Prevent Med, Lab Biostat, Moscow, Russia
关键词
D-dimer; platelet aggregation; thrombotic event; atherosclerosis;
D O I
10.1053/euhj.2001.3116
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To evaluate the frequency of arterial thrombotic events in patients with peripheral arterial occlusive disease during 3-5 years of follow-up and to determine whether baseline levels of haemostatic factors were related to the risk of future thrombotic events. Methods and Results One hundred and twenty-three patients, mean age 56 years, with peripheral arterial occlusive disease and intermittent claudication were followed prospectively for an average of 4.2 years. Fibrinogen, prothrombin fragment 1 + 2, D-dimer, tissue plasminogen activator, plasminogen activator inhibitor type I antigen and activity, plasmin-alpha(2)-antiplasmin complex, beta-thromboglobulin and ADP-induced platelet aggregation were measured at the recruitment. Thirty-eight new vascular events (15 fatal) were identified. Age- (and other clinical and laboratory variables) -adjusted relative risks (RR) of thrombotic events were significantly elevated (P < 0.05) per higher value of D-dimer (RR: 14.1, 95% CI 1.7; 115.8) and platelet aggregation was low (RR: 4.6, 95% CI 1.3; 16.3). Diabetes mellitus, cerebrovascular disease, and continuing deterioration of intermittent claudication at the recruitment were also independently associated with risk of thrombotic events in the multiple regression model (RR: 5.2, 95% CI 1.5; 17.5; RR: 8.6, 95% CI 2.7; 27.4; RR: 2.6, 95% CI 1.2; 5.7 respectively). Conclusion Elevated level of D-dimer and low platelet aggregation are independent haemostatic predictors of thrombotic events in patients with peripheral arterial occlusive disease. (C) 2002 Published by Elsevier Science Ltd on behalf of The European Society of Cardiology.
引用
收藏
页码:1309 / 1316
页数:8
相关论文
共 38 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]   A FUNCTIONAL PHOTOMETRIC ASSAY FOR PLASMA-FIBRINOGEN [J].
BECKER, U ;
BARTL, K ;
WAHLEFELD, AW .
THROMBOSIS RESEARCH, 1984, 35 (05) :475-484
[3]   Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes [J].
Bhatt, DL ;
Topol, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (12) :1549-1558
[4]   CLINICAL-ASSESSMENT OF LOW-MOLECULAR-WEIGHT HEPARIN EFFECTS IN PERIPHERAL VASCULAR-DISEASE [J].
CALABRO, A ;
PIARULLI, F ;
MILAN, D ;
ROSSI, A ;
COSCETTI, G ;
CREPALDI, G .
ANGIOLOGY, 1993, 44 (03) :188-195
[5]  
CHANDLER WL, 1989, CLIN CHEM, V35, P787
[6]   INCREASED FIBRIN TURNOVER AND HIGH PAI-1 ACTIVITY AS PREDICTORS OF ISCHEMIC EVENTS IN ATHEROSCLEROTIC PATIENTS - A CASE-CONTROL STUDY [J].
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
MUSSONI, L ;
DONATI, MB ;
CARDILLO, M ;
CATALANO, M ;
GABRIELLI, L ;
LOMBARDI, B ;
SPECCHIA, G ;
TAVAZZI, L ;
TREMOLI, E ;
POZZOLI, E ;
TURRI, M ;
CORTELLARO, M ;
COFRANCESCO, E ;
BOSCHETTI, C ;
CARDILLO, M ;
TORRI, M ;
RAINISIO, M ;
GENTILE, G ;
MOREO, G ;
BIANCHI, O ;
LEONARDI, P ;
COLOMBI, M ;
CATALANO, M ;
GALIMBERTI, P ;
RUSSO, U ;
CRESSOTTI, A ;
CARZANIGA, G ;
NOBILI, S ;
NINNO, D ;
DONATI, MB ;
IACOVIELLO, L ;
DEGAETANO, G ;
GABRIELLI, L ;
MARTELLI, E ;
CORSI, G ;
LORENZI, G ;
LOMBARDI, B ;
CARRIERO, MR ;
COLOMBO, R ;
SPECCHIA, G ;
CIOFFI, P ;
SCIRE, A ;
TAVAZZI, L ;
GIANNUZZI, P ;
CORRA, U ;
TEMPORELLI, L ;
MORA, F .
ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (10) :1412-1417
[7]   MORTALITY OVER A PERIOD OF 10 YEARS IN PATIENTS WITH PERIPHERAL ARTERIAL-DISEASE [J].
CRIQUI, MH ;
LANGER, RD ;
FRONEK, A ;
FEIGELSON, HS ;
KLAUBER, MR ;
MCCANN, TJ ;
BROWNER, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (06) :381-386
[8]  
DORMANDY J, 1989, J CARDIOVASC SURG, V30, P50
[9]   ROLE OF THROMBOSIS IN ATHEROSCLEROSIS AND ITS COMPLICATIONS [J].
FALK, E ;
FERNANDEZORTIZ, A .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (06) :B5-B11
[10]   CROSS-LINKED FIBRIN DEGRADATION PRODUCTS, PROGRESSION OF PERIPHERAL ARTERIAL-DISEASE, AND RISK OF CORONARY HEART-DISEASE [J].
FOWKES, FGR ;
LOWE, GDO ;
HOUSLEY, E ;
RATTRAY, A ;
RUMLEY, A ;
ELTON, RA ;
MACGREGOR, IR ;
DAWES, J .
LANCET, 1993, 342 (8863) :84-86